With upcoming T1D data due "early Q4, 2021", we could see share price spike to between 2.50 -3.50 before fading back down to low 2s before starting the climb back up for the further catalyst due 2022
All in the chart . Two possible entry levels .
Pay close attention to CCI alerts ,PPO and RSI before entering
Entertainment purpose only,not financial advice .
DISCLAIMER
This is in no way, shape or form, fluid and function, an analytical, qualitative or intelligent compte rendu. I am obviously not rich, so obviously I haven't made it with my own thinking, so definitely don't put faith in me. But maybe read and learn some things about a company that might just change the standard of care for quite a few diseases.
...
DISCLAIMER
This is in no way, shape or form, fluid and function, an analytical, qualitative or intelligent compte rendu. I am obviously not rich, so obviously I haven't made it with my own thinking, so definitely don't put faith in me. But maybe read and learn some things about a company that might just change the standard of care for quite a few diseases....
What Is a Short Squeeze?
A short squeeze occurs when a stock or other
asset jumps sharply higher, forcing traders who
had bet that its price would fall, to buy it in
order to forestall even greater losses. Their
scramble to buy only adds to the upward
pressure on the stock's price
KEY TAKEAWAYS
*A short squeeze accelerates a stock's price rise
as...
Major breakout on news and insider buys this morning.
Very volatile stock with many pumps in the past
so trade with great care.
I have highlighted levels of resistance (targets)
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
Can algorithms predict gap-up stocks?
I've been trying to find a systematic way to identify stocks that gap up in the morning and at first, it seemed like an impossible goal. Recently, I have identified a few key characteristic of gap-up stocks and the goal of this post is to test my theory.
The hypothesis:
1) low float. It has to have less than 20M shares...
vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference
FOMO/Hyping on twitter:
-Moneyline Mark@MoneylineMark
Adding $VTVT swing hold $2.86
-PJ Matlock@PJ_Matlock
$VTVT should be a good one tomorrow on this too
-TexMex@TraderTexMex
$VTVT heating up...
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon,...
Thinly traded micro cap vTv Therapeutics (NASDAQ:VTVT) jumps 67% premarket on robust volume on the heels of positive results from Part 2 of a Phase 2 clinical trial, Simplici-T1, evaluating TTP399 as oral adjunctive therapy to insulin in adults with type 1 diabetes (T1D).
Treatment with once-daily TTP399 resulted in statistically significant improvements in HbA1C...
